 PALO ALTO, Calif. and PROVIDENCE, R.I., April 13, 2021 GLOBE NEWSWIRE -- BridgeBio Pharma, Inc. NASDAQ: BBIO, and Brown University today announced a formal collaboration to advance research in genetically driven neurological disorders into potential life-changing medicines for patients. 